Ozempic, a GLP-1 medication, helps with blood sugar control and weight loss, whereas Zepbound combines multiple approaches to support fat reduction
Since the GHSR system also modulates other physiological functions such as GH secretion, it is necessary to expand understanding of the pathways involved and develop biased ligands to modulate only the therapeutically relevant signaling pathway (127)
[1] [5] According to the European Medicines Agency's European Public Assessment Report (EPAR) for Ozempic, clinical trial data and post-marketing surveillance have not established a direct causal link between semaglutide and muscle pain
(PubMed) Sawicka AK, Hartmane D, Lipinska P, Wojtowicz E, Lysiak-Szydlowska W, Olek RA
Science-Backed How GLP-1 treatment works GLP-1-based therapies support weight and metabolic health through coordinated effects on appetite signaling, glucose regulation, and cardiometabolic risk markers